Oncodesign Precision Medicine | Sustainability Performance
This company focuses on precision medicine, particularly in oncology. It engages in the development of targeted therapies and diagnostic tools to support personalized treatment approaches within the healthcare industry.
1995
France
1,001 - 5,000 employees
Biotechnology
$100K - 500K in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#4892
Overall#323
in France#65
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Environmental
Digital emissions
Digital Emissions
CO2e per visit (g)
Industry benchmark
B/M 0.26 g
C
Environmental ScoreScore C
Green HostingYes
Controversy level
- Oncodesign's drug discovery services involve animal testing for preclinical studies, raising ethical concerns about the extent of animal use.
